1 |
Ren Z,Cui G,Lu H, et al. Liver ischemic preconditioning (IPC) improves intestinal microbiota following liver transplantation in rats through 16s rDNA-based analysis of microbial structure shift[J]. PLoS One, 2013, 8(10): e75950.
|
2 |
童荔,杨志勤,易小猛, 等. 肝移植术后肠道菌群失调及其危险因素分析[J/CD]. 中华临床医师杂志:电子版, 2014, 8(5): 868-872.
|
3 |
Lu H,He J,Wu Z, et al. Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis[J]. Microb Ecol, 2013, 65(3): 781-791.
|
4 |
Bruls T,Weissenbach J. The human metagenome: our other genome?[J]. Hum Mol Genet, 2011, 20(R2): R142-R148.
|
5 |
Backhed F,Ley RE,Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine[J]. Science, 2005, 307(5717): 1915-1920.
|
6 |
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome[J]. Nature, 2012, 486(7402): 207-214.
|
7 |
Possemiers S,Bolca S,Verstraete W, et al. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals[J]. Fitoterapia, 2011, 82(1): 53-66.
|
8 |
Bruzzese E,Callegari ML,Raia V, et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial[J]. PLoS One, 2014, 9(2): e87796.
|
9 |
Kamada N,Seo SU,Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease[J]. Nat Rev Immunol, 2013, 13(5): 321-335.
|
10 |
Arumugam M,Raes J,Pelletier E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346): 174-180.
|
11 |
Choi JH,Kim GB,Cha CJ. Spatial heterogeneity and stability of bacterial community in the gastrointestinal tracts of broiler chickens[J]. Poult Sci, 2014, 93(8): 1942-1950.
|
12 |
Fukuda S,Toh H,Taylor TD, et al. Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters[J]. Gut Microbes, 2012, 3(5): 449-454.
|
13 |
Sayin SI,Wahlstrom A,Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J]. Cell Metab, 2013, 17(2): 225-235.
|
14 |
Li F,Jiang C,Krausz KW, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity[J]. Nat Commun, 2013, 4: 2384.
|
15 |
Shankar V,Hamilton MJ,Khoruts A, et al. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation[J]. Microbiome, 2014, 2: 13.
|
16 |
Renz H,Brandtzaeg P,Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation[J]. Nat Rev Immunol, 2012, 12(1): 9-23.
|
17 |
Round JL,Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease[J]. Nat Rev Immunol, 2009, 9(5): 313-323.
|
18 |
Bouskra D,Brezillon C,Berard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis[J]. Nature, 2008, 456(7221): 507-510.
|
19 |
Laycock G,Sait L,Inman C, et al. A defined intestinal colonization microbiota for gnotobiotic pigs[J]. Vet Immunol Immunopathol, 2012, 149(3-4): 216-224.
|
20 |
Gaboriau-Routhiau V,Rakotobe S,Lecuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses[J]. Immunity, 2009, 31(4): 677-689.
|
21 |
Ivanov II,Atarashi K,Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria[J]. Cell, 2009, 139(3): 485-498.
|
22 |
Hand TW,Dos SL,Bouladoux N, et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses[J]. Science, 2012, 337(6101): 1553-1556.
|
23 |
Yoon WS,Choi HJ,Park YK. Salmonella typhimurium harboring plasmid expressing interleukin-12 induced attenuation of infection and protective immune responses[J]. J Gen Appl Microbiol, 2011, 57(2): 115-122.
|
24 |
Round JL,Lee SM,Li J, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota[J]. Science, 2011, 332(6032): 974-977.
|
25 |
Atarashi K,Tanoue T,Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species[J]. Science, 2011, 331(6015): 337-341.
|
26 |
Maynard CL,Elson CO,Hatton RD, et al. Reciprocal interactions of the intestinal microbiota and immune system[J]. Nature, 2012, 489(7415): 231-241.
|
27 |
《中华消化杂志》编委会, 王兴鹏. 肠道菌群失调诊断治疗建议[J]. 中华消化杂志, 2009, 29(5): 335-337.
|
28 |
Xu MQ,Cao HL,Wang WQ, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders[J]. World J Gastroenterol, 2015, 21(1): 102-111.
|
29 |
Mckay S,Gaudier E,Campbell DI, et al. Environmental enteropathy: new targets for nutritional interventions[J]. Int Health, 2010, 2(3): 172-180.
|
30 |
Armougom F,Henry M,Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients[J]. PLoS One, 2009, 4(9): e7125.
|
31 |
Rizzello M,De Angelis F,Campanile FC, et al. Effect of gastrointestinal surgical manipulation on metabolic syndrome: a focus on metabolic surgery[J]. Gastroenterol Res Pract, 2012: 670418.
|
32 |
Stefater MA,Wilson-Perez HE,Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons[J]. Endocr Rev, 2012, 33(4): 595-622.
|
33 |
廖博雅,王莎莎,张军东, 等. 肠道微生物在人类疾病中的作用[J]. 胃肠病学, 2015, 20(2): 126-128.
|
34 |
Malamut G,Verkarre V,Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease[J]. Am J Gastroenterol, 2010, 105(10): 2262-2275.
|
35 |
Compare D,Coccoli P,Rocco A, et al. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease[J]. Nutr Metab Cardiovasc Dis, 2012, 22(6): 471-476.
|
36 |
Xie YR,Liu SL,Liu X, et al. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation[J]. Transplant Proc, 2011, 43(10): 3973-3979.
|
37 |
刘霞,刘社兰,解奕瑞, 等. 基于16S rRNA基因和细菌基因组间重复序列的DNA指纹图谱技术对肝硬化大鼠肝移植后肠道菌群多样性的研究[J]. 中国微生态学杂志, 2010, 22(3): 193-198.
|
38 |
Xie Y,Luo Z,Li Z, et al. Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation[J]. Microb Ecol, 2012, 64(2): 546-554.
|
39 |
Ren Z,Jiang J,Lu H, et al. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats[J]. Transplantation, 2014, 98(8): 844-852.
|
40 |
Wu ZW,Ling ZX,Lu HF, et al. Changes of gut bacteria and immune parameters in liver transplant recipients[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(1): 40-50.
|
41 |
Arai M,Mochida S,Ohno A, et al. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models[J]. Hepatology, 1998, 27(1): 123-127.
|
42 |
Katchman E,Marquez M,Bazerbachi F, et al. A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients[J]. Transpl Infect Dis, 2014, 16(4): 539-547.
|
43 |
Mccafferty K,Forbes S,Thiemermann C, et al. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities[J]. Dis Model Mech, 2014, 7(12): 1321-1333.
|
44 |
Wu J,Feng X,Huang H, et al. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial[J]. J Surg Res, 2014, 188(1): 303-308.
|
45 |
Mullard A. Microbiology: the inside story[J]. Nature, 2008, 453(7195): 578-580.
|
46 |
Rayes N,Seehofer D,Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial[J]. Am J Transplant, 2005, 5(1): 125-130.
|
47 |
Xing HC,Li LJ,Xu KJ, et al. Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury[J]. J Gastroenterol Hepatol, 2006, 21(4): 647-656.
|
48 |
Ren ZG,Liu H,Jiang JW, et al. Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(5): 489-496.
|
49 |
Xie Y,Chen H,Zhu B, et al. Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation[J]. Microb Ecol, 2014, 68(4): 871-880.
|
50 |
El FR,Bangar H,Haslam DB. The molecular basis of Clostridium difficile disease and host response[J]. Curr Opin Gastroenterol, 2015, 31(1): 24-29.
|
51 |
Zhang F,Luo W,Shi Y, et al. Should we standardize the 1, 700-year-old fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(11): 1755, 1755-1756.
|
52 |
Eiseman B,Silen W,Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis[J]. Surgery, 1958, 44(5): 854-859.
|
53 |
Armstrong MJ,Pathmakanthan S,Iqbal TH. Fecal microbiota transplantation for Clostridium difficile infection[J]. JAMA, 2015, 313(7): 725-726.
|
54 |
Ray A,Smith R,Breaux J. Fecal microbiota transplantation for Clostridium difficile infection: the Ochsner experience[J]. Ochsner J, 2014, 14(4): 538-544.
|
55 |
Kelly CR,de Leon L,Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results[J]. J Clin Gastroenterol, 2012, 46(2): 145-149.
|
56 |
Gough E,Shaikh H,Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection[J]. Clin Infect Dis, 2011, 53(10): 994-1002.
|
57 |
Kim JE,Gweon TG,Yeo CD, et al. A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation[J]. World J Gastroenterol, 2014, 20(35): 12687-12690.
|
58 |
Bakken JS,Borody T,Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation[J]. Clin Gastroenterol Hepatol, 2011, 9(12): 1044-1049.
|
59 |
Angelberger S,Reinisch W,Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation[J]. Am J Gastroenterol, 2013, 108(10): 1620-1630.
|
60 |
van Nood E,Dijkgraaf MG,Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile[J]. N Engl J Med, 2013, 368(22): 2145.
|
61 |
Grehan MJ,Borody TJ,Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora[J]. J Clin Gastroenterol, 2010, 44(8): 551-561.
|
62 |
Youngster I,Hohmann EL. Fecal microbiota transplantation for Clostridium difficile infection-reply[J]. JAMA, 2015, 313(7): 726.
|
63 |
Rao K,Young VB. Fecal microbiota transplantation for the management of Clostridium difficile infection[J]. Infect Dis Clin North Am, 2015, 29(1): 109-122.
|
64 |
Sipponen T,Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease[J]. Scand J Gastroenterol, 2015, 50(1): 74-80.
|